Stablepharma completes the first close of Series A raise with £2 million following a number of high-profile partnership announcements

UK-based biotech aims to be the first fridge-free vaccine company in the world. Stablepharma Ltd, a UK-based biotech who have a novel technology platform for fridge-free vaccines, has announced the completion of the first close of their Series A, with £2 million. Funding came from existing shareholders and new investors such as Ascension Ventures and […]

Read More